scholarly article | Q13442814 |
P2093 | author name string | Dickinson DP | |
P2860 | cites work | Human cathepsin F. Molecular cloning, functional expression, tissue localization, and enzymatic characterization | Q22008028 |
Lymphopain, a cytotoxic T and natural killer cell-associated cysteine proteinase | Q22008032 | ||
Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone | Q24309351 | ||
Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and a unique chromosomal location | Q24310097 | ||
Human dipeptidyl-peptidase I. Gene characterization, localization, and expression | Q24311837 | ||
Cystatin F Is a Glycosylated Human Low Molecular Weight Cysteine Proteinase Inhibitor | Q24312357 | ||
Evolutionary families of peptidases | Q24527684 | ||
Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S | Q24528220 | ||
Caspases: the executioners of apoptosis | Q24530218 | ||
L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L | Q24531160 | ||
Secreted cathepsin L generates endostatin from collagen XVIII | Q24599981 | ||
Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages | Q24676370 | ||
Two distinct gene subfamilies within the family of cysteine protease genes | Q36216964 | ||
An acid protease secreted by transformed cells interferes with antigen processing | Q36218951 | ||
Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. | Q36301521 | ||
The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant | Q36354993 | ||
Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation | Q36475793 | ||
Direct evidence for the elevated synthesis and secretion of procathepsin L in the distal caput epididymis of boar | Q36671752 | ||
Cloning and expression of a rat placental cDNA encoding a novel cathepsin L-related protein | Q36705688 | ||
Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. | Q36731034 | ||
Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts | Q36800896 | ||
Alterations in phagocyte function and periodontal infection | Q36831541 | ||
Molecular cloning, chromosomal localization, and expression of murine dipeptidyl peptidase I. | Q36853423 | ||
The neutrophil: mechanisms of controlling periodontal bacteria | Q36894586 | ||
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells | Q37384330 | ||
Tissue destruction by neutrophils | Q38264463 | ||
Neutrophil Migration Into the Gingival Sulcus Is Associated With Transepithelial Gradients of Interleukin‐8 and ICAM‐1 | Q38578614 | ||
Lysosomal enzymes and their receptors | Q39479416 | ||
Cytokines: making the right choice | Q39696739 | ||
Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases | Q35691389 | ||
Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells | Q35787073 | ||
Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome | Q36158535 | ||
Novel structures CTLA-2 alpha and CTLA-2 beta expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions | Q36198437 | ||
Localisation of a gene for prepubertal periodontitis to chromosome 11q14 and identification of a cathepsin C gene mutation | Q24681399 | ||
Basic local alignment search tool | Q25938991 | ||
Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. | Q27617244 | ||
NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP | Q27620280 | ||
The crystal structure of human procathepsin K | Q27766712 | ||
Structure and chromosomal assignment of the human cathepsin K gene | Q28117956 | ||
Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization | Q28137688 | ||
Cathepsin expression during skeletal development | Q28138976 | ||
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis | Q28139155 | ||
Immunocytochemical localization of cathepsins B and G in odontoclasts of human deciduous teeth | Q28207591 | ||
Direct mapping of seven genes encoding human type 2 cystatins to a single site located at 20p11.2 | Q28236726 | ||
Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms | Q28238221 | ||
Cathepsin B | Q28245818 | ||
The human type 2 cystatin gene family consists of eight to nine members, with at least seven genes clustered at a single locus on human chromosome 20 | Q28253236 | ||
Cross-Class Inhibition of the Cysteine Proteinases Cathepsins K, L, and S by the Serpin Squamous Cell Carcinoma Antigen 1: A Kinetic Analysis | Q28268059 | ||
The structure of the mouse cathepsin B gene and its putative promoter | Q28272190 | ||
Inactivation of human cystatin C and kininogen by human cathepsin D | Q28272426 | ||
Cathepsin B, Cathepsin H, and cathepsin L | Q28277583 | ||
Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification | Q28280533 | ||
Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency | Q28284581 | ||
Genomic structure and chromosomal localization of the human cathepsin O gene (CTSO) | Q28286845 | ||
Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution | Q28290432 | ||
Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L | Q28290438 | ||
Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2 | Q28304561 | ||
Emerging roles for cysteine proteases in human biology | Q28306260 | ||
Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas | Q28307471 | ||
The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L | Q28361595 | ||
The inhibition of macrophage protein turnover by a selective inhibitor of thiol proteinases | Q28367093 | ||
Mouse cathepsin M, a placenta-specific lysosomal cysteine protease related to cathepsins L and P | Q28509398 | ||
Cathepsin Q, a novel lysosomal cysteine protease highly expressed in placenta | Q28570157 | ||
Rat testin is a newly identified component of the junctional complexes in various tissues whose mRNA is predominantly expressed in the testis and ovary | Q28572184 | ||
Characterization of mouse cathepsin R, a new member of a family of placentally expressed cysteine proteases | Q28585681 | ||
Cathepsin J, a novel murine cysteine protease of the papain family with a placenta-restricted expression | Q28586755 | ||
Surface activation of pro-cathepsin L | Q28592047 | ||
Cathepsin S required for normal MHC class II peptide loading and germinal center development | Q28611850 | ||
Cathepsin L: Critical Role in Ii Degradation and CD4 T Cell Selection in the Thymus | Q28613227 | ||
Caspases: Enemies Within | Q29547315 | ||
A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis | Q29617776 | ||
Matrix metalloproteinases: a review | Q29620220 | ||
Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells | Q30321132 | ||
Cathepsin S and related lysosomal endopeptidases. | Q30321425 | ||
Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. | Q30321506 | ||
Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain | Q30696787 | ||
Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption | Q30773401 | ||
Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene | Q30854542 | ||
Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts | Q31417108 | ||
Human cathepsin X: A novel cysteine protease of the papain family with a very short proregion and unique insertions1 | Q32021129 | ||
Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation | Q40096626 | ||
Human plasma proteinase inhibitors | Q40107740 | ||
Regulation of proteolytic activity in tissues | Q40575091 | ||
Role of suspected periodontopathogens in microbiological monitoring of periodontitis | Q40789891 | ||
Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation | Q40818408 | ||
Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. | Q40925415 | ||
Expression of cathepsin K in lung epithelial cells | Q40963587 | ||
Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile | Q40986849 | ||
How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway | Q41020969 | ||
Cytokine-inducing components of periodontopathogenic bacteria | Q41180923 | ||
Neural crest apoptosis and the establishment of craniofacial pattern: an honorable death | Q41212560 | ||
Expression of rat cathepsin S in phagocytic cells | Q41226814 | ||
Alpha 2-macroglobulin in gingival fluid: correlation with alveolar bone loss in periodontal disease | Q41247703 | ||
Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L | Q41259127 | ||
Giant cells in arthritic synovium | Q41260586 | ||
Differential recognition of alpha 1-antitrypsin-elastase and alpha 1-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein | Q41370261 | ||
Multi-step processing of procathepsin L in vitro | Q41436588 | ||
The proregion of cathepsin L is required for proper folding, stability, and ER exit | Q41467775 | ||
Cytokines and the hepatic acute phase response | Q41474260 | ||
Proenzyme from of cathepsin L produced by thymic epithelial cells promotes proliferation of immature thymocytes in the presence of IL-1, IL-7, and anti-CD3 antibody | Q41536790 | ||
Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA. | Q41555093 | ||
Caspases: Intracellular Signaling by Proteolysis | Q41656258 | ||
Protease trafficking in two primitive eukaryotes is mediated by a prodomain protein motif | Q41668260 | ||
MHC class II molecules, cathepsins, and La/SSB proteins in lacrimal acinar cell endomembranes | Q41702760 | ||
Stimulation with carbachol alters endomembrane distribution and plasma membrane expression of intracellular proteins in lacrimal acinar cells | Q41712044 | ||
Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues | Q41849893 | ||
Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme | Q42064898 | ||
Quantification of cathepsins B and L in cells | Q42537421 | ||
Primary structure of bovine cathepsin S. Comparison to cathepsins L, H, B and papain | Q42622492 | ||
Expression of cysteine proteases in extraembryonic tissues during mouse embryogenesis | Q42807530 | ||
Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines | Q42813782 | ||
A partial catalog of proteins secreted by epidermal keratinocytes in culture | Q42816120 | ||
Analysis of where and which types of proteinases participate in lysosomal proteinase processing using bafilomycin A1 and Helicobacter pylori Vac A toxin | Q42817555 | ||
Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro | Q42819271 | ||
Multiple processing of procathepsin L to cathepsin L in vivo | Q42824669 | ||
Elastinolytic activity of human cathepsin L. | Q42867583 | ||
Mode of activation of the precursor to cathepsin L: implication for matrix degradation in arthritis | Q44855335 | ||
Neutrophil chemotactic activity is modulated by human cystatin C, an inhibitor of cysteine proteases | Q45262126 | ||
Cytokine Expression in Periodontal Health and Disease | Q45297941 | ||
Purification and characterization of cathepsin J from rat liver | Q46117343 | ||
Gene structure and 5'-upstream sequence of rat cathepsin L. | Q46984019 | ||
Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain rea | Q47685856 | ||
Testin Secreted by Sertoli Cells Is Associated with the Cell Surface, and Its Expression Correlates with the Disruption of Sertoli-Germ Cell Junctions but Not the Inter-Sertoli Tight Junction | Q47724366 | ||
Expression in Escherichia coli, refolding, and purification of human procathepsin K, an osteoclast-specific protease | Q47851649 | ||
Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. | Q47872621 | ||
Calpain: a protease in search of a function? | Q47923112 | ||
Processing of the papain precursor. The ionization state of a conserved amino acid motif within the Pro region participates in the regulation of intramolecular processing | Q48073777 | ||
A novel family of cathepsin L-like (CTSLL) sequences on human chromosome 10q and related transcripts | Q48077716 | ||
Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: an in situ hybridization study | Q48150354 | ||
Cyclic protein-2, a secretory product of rat Sertoli cells, is the proenzyme form of cathepsin L. | Q48197841 | ||
Cathepsin B-mediated activation of the proinflammatory caspase-11. | Q49171734 | ||
Investigations into the cellular contribution to host tissue proteases and inhibitors in gingival crevicular fluid | Q50528244 | ||
A possible association of α1‐antitrypsin deficiency with the periodontal condition in adults | Q50868482 | ||
Developmental expression of cathepsin L and c-rasHa in the mouse placenta | Q51196704 | ||
Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. | Q52190101 | ||
Testin is tightly associated with testicular cell membrane upon its secretion by sertoli cells whose steady-state mRNA level in the testis correlates with the turnover and integrity of inter-testicular cell junctions | Q52195730 | ||
Ultrastructural localization of cathepsin B in gingival tissue from chronic periodontitis patients | Q53994638 | ||
Cathepsin K Knockout Mice Develop Osteopetrosis Due to a Deficit in Matrix Degradation but Not Demineralization | Q57272396 | ||
Prolactin Up-Regulates Cathepsin B and D Expression in Minor Salivary Glands of Patients with Sjögren's Syndrome | Q58862290 | ||
Cathepsin K mRNA Detection Is Restricted to Osteoclasts During Fetal Mouse Development | Q32066782 | ||
The potential role of chemokines and inflammatory cytokines in periodontal disease progression | Q33588763 | ||
Activation of the plasma kallikrein/kinin system on endothelial cells | Q33650374 | ||
Suicidal tendencies: apoptotic cell death by caspase family proteinases | Q33684353 | ||
The lysosomal cysteine proteases | Q33689936 | ||
Making sense of the limb-girdle muscular dystrophies | Q33701932 | ||
Osteopetrosis and osteoporosis: two sides of the same coin | Q33724069 | ||
Proteolysis and cell migration: creating a path? | Q33744936 | ||
Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome | Q33755016 | ||
Unraveling the role of proteases in cancer | Q33838143 | ||
Lysosomal cysteine proteases: more than scavengers | Q33857460 | ||
Caspases - controlling intracellular signals by protease zymogen activation | Q33857511 | ||
Full-length cDNA of human cathepsin F predicts the presence of a cystatin domain at the N-terminus of the cysteine protease zymogen | Q33858403 | ||
Human cathepsins F and W: A new subgroup of cathepsins | Q33864371 | ||
Genomic organization and chromosomal localization of the human cathepsin L2 gene. | Q33866167 | ||
Human cathepsin X: A cysteine protease with unique carboxypeptidase activity | Q33875510 | ||
Proteolysis in MHC class II antigen presentation: who's in charge? | Q33885986 | ||
Identification and molecular cloning of cathepsin P, a novel human putative cysteine protease of the papain family | Q33888252 | ||
Tissue expression and immunolocalization of a novel human cathepsin P. | Q33888257 | ||
Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases | Q33889747 | ||
Murine and human cathepsin Z: cDNA-cloning, characterization of the genes and chromosomal localization | Q33897792 | ||
Noncaspase proteases in apoptosis | Q34037785 | ||
Role of bacterial proteinases in matrix destruction and modulation of host responses | Q34200755 | ||
Uptake of extracellular enzyme by a novel pathway is a major determinant of cathepsin L levels in human macrophages | Q34255942 | ||
Biochemical composition of human saliva in relation to other mucosal fluids | Q34294679 | ||
Families of cysteine peptidases. | Q34317817 | ||
Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages | Q34385281 | ||
Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes | Q34422070 | ||
Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c | Q34457741 | ||
Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases | Q34487989 | ||
Genomic Structure, Chromosomal Localization, and Expression of Human Cathepsin W | Q34749685 | ||
Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase | Q35016459 | ||
Cystatins--inhibitors of cysteine proteinases | Q35361416 | ||
Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo | Q35558255 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 238-275 | |
P577 | publication date | 2002-01-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Journal of Dental Research | Q6295082 |
P1476 | title | Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease | |
P478 | volume | 13 |
Q50948847 | A New Sugarcane Cystatin Strongly Binds to Dental Enamel and Reduces Erosion |
Q35085725 | A snapshot of the Ixodes scapularis degradome |
Q35630007 | Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. |
Q36227942 | Analysis of the human saliva proteome. |
Q33693412 | Analysis of the transcriptome of adult Dictyocaulus filaria and comparison with Dictyocaulus viviparus, with a focus on molecules involved in host-parasite interactions |
Q36543714 | Anti-serpin Antibody-mediated Regulation of Proteases in Autoimmune Diabetes |
Q34377103 | Biochemistry and clinical role of human cystatin C. |
Q34413796 | Bovipain-2, the falcipain-2 ortholog, is expressed in intraerythrocytic stages of the tick-transmitted hemoparasite Babesia bovis |
Q36640223 | Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles |
Q24336204 | Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells |
Q38420668 | Cathepsin S: therapeutic, diagnostic, and prognostic potential. |
Q34631788 | Clinical Efficacy of a Specifically Targeted Antimicrobial Peptide Mouth Rinse: Targeted Elimination of <i>Streptococcus mutans</i> and Prevention of Demineralization |
Q41994145 | Crystallization and preliminary X-ray diffraction studies of the precursor protein of a thermostable variant of papain |
Q90669948 | Cystatins in Health and Diseases |
Q35129249 | Cysteine cathepsins in human carious dentin |
Q26860406 | Cysteine cathepsins: from structure, function and regulation to new frontiers |
Q38169006 | Dentin biomodification: strategies, renewable resources and clinical applications |
Q43575189 | Development of a saliva collection device for use in the field |
Q38712591 | Effect of pH on dentin protease inactivation by carbodiimide. |
Q34361835 | Evolution of C, D and S-type cystatins in mammals: an extensive gene duplication in primates |
Q44433403 | Gene Microarrays in Hippocampal Aging: Statistical Profiling Identifies Novel Processes Correlated with Cognitive Impairment |
Q24303274 | Human epididymis protein-4 (HE-4): a novel cross-class protease inhibitor |
Q40285536 | Identification and characterization of a cathepsin L-like cysteine protease from Rhipicephalus (Boophilus) annulatus. |
Q42025701 | Identification of parasite-responsive cysteine proteases in Manduca sexta. |
Q35684193 | Identification, Characterization and Down-Regulation of Cysteine Protease Genes in Tobacco for Use in Recombinant Protein Production |
Q36902096 | Immune and regulatory functions of neutrophils in inflammatory bone loss |
Q35052350 | Immunohistochemical expression of cathepsin L in atopic dermatitis and lichen planus |
Q93198245 | Involvement of Cathepsins in Innate and Adaptive Immune Responses in Periodontitis |
Q43144436 | Involvement of a cysteine protease in the secretion process of human xylosyltransferase I. |
Q28741956 | Limitations in bonding to dentin and experimental strategies to prevent bond degradation |
Q37147938 | Long-lasting tissue inflammatory processes trigger autoimmune responses to extracellular matrix molecules. |
Q92153915 | Molecular Signaling Regulating Endometrium-Blastocyst Crosstalk |
Q33505847 | Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions |
Q37594566 | Neutrophil homeostasis and periodontal health in children and adults |
Q33638719 | Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B. |
Q36914323 | Nuclear cathepsin F regulates activation markers in rat hepatic stellate cells |
Q26866319 | Optimizing dentin bond durability: control of collagen degradation by matrix metalloproteinases and cysteine cathepsins |
Q49335018 | Overexpression of asparaginyl endopeptidase is significant for esophageal carcinoma metastasis and predicts poor patient prognosis |
Q38092835 | Overview of Clinical Alternatives to Minimize the Degradation of the Resin-dentin Bonds |
Q39937000 | P. gingivalis regulates the expression of Cathepsin B and Cystatin C. |
Q47135856 | Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma |
Q36401848 | Proteinases in the joint: clinical relevance of proteinases in joint destruction |
Q49612416 | Recent Advances in Adhesive Bonding - The Role of Biomolecules, Nanocompounds, and Bonding Strategies in Enhancing Resin Bonding to Dental Substrates |
Q47843867 | Role of Cathepsin S in Periodontal Inflammation and Infection |
Q54241034 | Role of cathepsin S In periodontal wound healing-an in vitro study on human PDL cells. |
Q38204999 | Role of genetic factors in the pathogenesis of aggressive periodontitis. |
Q35033473 | Salivary (SD-type) cystatins: over one billion years in the making--but to what purpose? |
Q53573454 | Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma. |
Q37802873 | Salivary peptidomics. |
Q27652649 | Structural elucidation of the Cys-His-Glu-Asn proteolytic relay in the secreted CHAP domain enzyme from the human pathogenStaphylococcus saprophyticus |
Q52334096 | Targeted proteomics guided by label-free global proteome analysis in saliva reveal transition signatures from health to periodontal disease. |
Q92150617 | The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance |
Q37406971 | The biology of cystatin M/E and its cognate target proteases. |
Q39775765 | The effects of host derived metalloproteinases on dentin bond and the role of MMPs inhibitors on dentin matrix degradation |
Q35000607 | The proline-rich motif of the proDer p 3 allergen propeptide is crucial for protease-protease interaction |
Q58040472 | Towards defining the whole salivary peptidome |
Q34399545 | Transcriptional profiling of bone marrow stromal cells in response to Porphyromonas gingivalis secreted products |
Search more.